KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Asset Utilization Ratio for 17 consecutive years, with 0.37 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 2.04% year-over-year to 0.37; the TTM value through Mar 2026 reached 0.37, down 2.04%, while the annual FY2025 figure was 0.37, 8.65% down from the prior year.
  • Asset Utilization Ratio hit 0.37 in Q1 2026 for Regeneron Pharmaceuticals, up from 0.36 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.4 in Q4 2023 and bottomed at 0.21 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.33, with a median of 0.36 recorded in 2025.
  • Year-over-year, Asset Utilization Ratio plummeted 63.77% in 2022 and then soared 92.45% in 2023.
  • Regeneron Pharmaceuticals' Asset Utilization Ratio stood at 0.21 in 2022, then skyrocketed by 92.45% to 0.4 in 2023, then decreased by 6.07% to 0.38 in 2024, then dropped by 5.92% to 0.36 in 2025, then grew by 3.13% to 0.37 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.37, 0.36, and 0.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.